Extensive-stage Small Cell Lung Cancer Clinical Trial
Official title:
Phase II Clinical Trial of Anlotinib Combined With Etoposide and Platinum in the Treatment of Extensive Stage Small Cell Lung Cancer
To evaluate the progression free survival of patients with extensive stage small cell lung cancer treated with anlotinib combined with EP/CE regimen
To evaluate the progression free survival of patients with extensive stage small cell lung cancer treated with anlotinib combined with EP/CE regimen To evaluate the safety, tolerability, overall survival (OS), objective response rate (ORR), disease control rate (DCR), and quality of life (QoL) of patients with extensive stage small cell lung cancer treated with anlotinib ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05509699 -
Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer
|
Phase 2 | |
| Recruiting |
NCT05975944 -
Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT04562337 -
A Phase II Clinical Study of SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in Extensive Small Cell Lung Cancer
|
Phase 2 | |
| Completed |
NCT00616109 -
Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC
|
Phase 2 | |
| Active, not recruiting |
NCT04373369 -
Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
|
Phase 2 | |
| Recruiting |
NCT04254471 -
This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT04774380 -
Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer
|
Phase 3 | |
| Active, not recruiting |
NCT01555710 -
Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)
|
Phase 3 | |
| Completed |
NCT00682981 -
A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04397003 -
Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
|
Phase 2 | |
| Recruiting |
NCT04702880 -
A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT04487756 -
Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03135977 -
Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy
|
Phase 2 | |
| Completed |
NCT03913455 -
Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer
|
Phase 2 | |
| Recruiting |
NCT04663438 -
Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC
|
||
| Not yet recruiting |
NCT03971214 -
PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT04101357 -
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT04404543 -
A Study of SYHA1807 in Subjects With Extensive-Stage Small Cell Lung Cancer
|
Phase 1 | |
| Completed |
NCT04636762 -
A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
|
Phase 2 | |
| Completed |
NCT02323737 -
Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer
|
Phase 2 |